Symlin pramlintide: AMLN plans to run a double-blind, placebo-controlled dose titration study in 250 patients with Type I diabetes who are actively trying to im

The dose titration study, which is expected to start this quarter, will evaluate safety, HbA1c levels and insulin usage. Patients will receive 1 month of Symlin dose titration and insulin adjustment. ...